Go to content
1 in 8 pregnant people have a disability, but significant gaps exist in the provision of accessible care 
Read ICES 2023/26 Strategic Plan "Evidence. For Everyone."
Subscribe to ICES news. Valuable insights straight to your inbox!
Photo of Laura Rosella

Laura Rosella

Senior Adjunct Scientist (Full Status) ICES UofT Site Director
Populations & Public Health Research Program

Biography

Laura Rosella holds a BSc (Hons) in statistics and life sciences, an MHSc in community health and epidemiology and a PhD in epidemiology, all from the University of Toronto. Following her doctoral work, she completed a postdoctoral fellowship through the CIHR Strategic Training Program in Public Health Policy.

Dr. Rosella's research is focused on population risk tools and public health intervention assessment as applied to obesity and diabetes. In addition, she is interested in the integration of scientific evidence and tools into public health decision-making. She is the principal investigator on two CIHR-funded research grants focused on quantifying future risk and burden of type 2 diabetes in Canada and guiding the adaption, implementation and evaluation of the Diabetes Population Risk Tool (DPoRT) in practice.

Dr. Rosella joined ICES as an adjunct scientist in 2012.

  • PhD, Epidemiology, Dalla Lana School of Public Health, University of Toronto
  • MPH, Community Health and Epidemiology, Dalla Lana School of Public Health, University of Toronto
  • BSc, Life Sciences and Statistics, University of Toronto
  • Health and wellness promotion
  • Endocrine and metabolic disorders
  • Social determinants of health
  • Health services research
  • Diet and nutrition
  • Affiliate Scientist, Institute for Better Health, Trillium Health Partners
  • Faculty Affiliate, Vector Institute for Artificial Intelligence
  • Member, Banting and Best Diabetes Centre, Vulnerable Populations/Population Health

ICES Grants

Grant
2021 - 2022

Impact of the COVID-19 pandemic on type 2 diabetes incidence: finding synergy among science, policy, and action

Granting Agency
Canadian Institutes of Health Research
Principal Investigators
Booth GL
Co-Investigators
Campbell DJ, Fazli GS, Mishra S, Moineddin R, Parsons JA, Rosella LC, Shah BR, Taylor GW
Grant Type
Project Grant
Grant Amount
$100,000
Grant
2021 - 2022

Person-centred segmentation: characterizing population segments to inform care

Granting Agency
Canadian Institutes of Health Research
Principal Investigators
Kuluski KH, Rosella LC
Co-Investigators
Donnelly CA, Green ME, Logozzo J, Mansfield EA, McCarthy L, Slater MB, Wood B
Grant Type
Project Grant
Grant Amount
$100,000
Grant
2021 - 2022

Intergenerational impacts of diabetes among First Nations mothers and their children

Granting Agency
Canadian Institutes of Health Research
Principal Investigators
Shah BR
Co-Investigators
Funnell S, Green ME, Jones C, Mulder C, Phillips-Beck W, Rosella LC, Wahi G, Walker J, Wicklow BA
Grant Type
Project Grant
Grant Amount
$100,000
Grant
2019 - 2020

Health system evaluation of the gap in treatment for the delivery of opioid agonist treatments among individuals with opioid use disorder in Ontario

Granting Agency
Canadian Institutes of Health Research
Principal Investigators
Bayoumi AM, Fairclough L, Leece P
Co-Investigators
Kahan M, Taha SA, Gomes T, Kendall C, Manson H, Nosyk BP, Rosella LC, Smith B, Strike CJ, Yu M
Grant Type
Operating Grant: Evaluation of Interventions to Address the Opioid Crisis
Grant Amount
$99,997
Grant
2018 - 2020

Influenza vaccines, statins, and laboratory-confirmed influenza outcomes in older adults: can vaccines and statins reduce the burden of influenza?

Granting Agency
Canadian Institutes of Health Research
Principal Investigators
Kwong J
Co-Investigators
Buchan S, Campitelli M, Rosella L, Schwartz K
Grant Type
Project Scheme Grant
Grant Amount
$202,725
Grant
2016 - 2021

Population health analytics in action: improving impact, sustainability and equity in the healthcare system

Granting Agency
Canadian Institutes of Health Research
Principal Investigators
Rosella L
Co-Investigators
Henry D, Stukel T, Walker J, Wodchis W
Grant Type
Foundation Scheme Grant
Grant Amount
$1,155,257
Grant
2015 - 2022

Building healthier cities: a Canadian initiative to identify environmental solutions to curb obesity (the “Healthy Cities, Healthier Lives” Research Program)

Granting Agency
Canadian Institutes of Health Research
Principal Investigators
Booth G
Co-Investigators
Chen H, Hoch J, Moineddin R, Rosella L
Grant Type
Foundation Scheme Grant
Grant Amount
$1,250,340
Grant
2015 - 2018

Population health impact assessment tools: using population health data to imrpove chronic disease prediction

Granting Agency
Canadian Institutes of Health Research
Principal Investigators
Manuel D
Co-Investigators
Jha P, Rosella L, Tu J
Grant Type
Operating Grant
Grant Amount
$124,739
Grant
2015 - 2017

Using comprehensive multi-linked mortality files to evaluate health system functioning and inform health system planning in Ontario

Granting Agency
Canadian Institutes of Health Research
Principal Investigators
Rosella L
Co-Investigators
Gershon A, Guttman A, Henry D, Jha P, Manuel D, Tu J
Grant Type
Operating Grant
Grant Amount
$429,438
Grant
2015 - 2016

Supporting decision-making for the preventation of chronic diseases and reduction of high healthcare utilization

Granting Agency
CIHR-PHSI
Principal Investigators
Rosella L
Co-Investigators
Stukel T, Booth G
Grant Type
CIHR Partnership for Health System Improvement (PHSI) Grant
Grant Amount
$399,999
See All

Awards & Recognition

Awards & Recognition
23/07/2018

Connaught Global Challenge Award

2018: Dr. Laura Rosella awarded $250,000 to launch a global network to advance innovative research and training in predictive analytics. Read more.

Awards & Recognition
03/07/2018

Top 40 under 40

2018: Dr. Laura Rosella named one of Canada's Top 40 Under 40. The annual list recognizes the achievements of 40 Canadians who have demonstrated remarkable success while under 40 years of age.

Awards & Recognition
15/09/2017

The Bill Silverman Prize

2017: Awarded to Drs. Laura Rosella and David Henry for the paper “Risk of bias in systematic reviews of non-randomized studies of adverse cardiovascular effects of thiazolidinediones and cyclooxygenase-2 inhibitors: application of a new Cochrane risk of bias tool” by Cochrane at its annual summit. The prize is offered annually and explicitly acknowledges Cochrane's value of criticism, with a view to helping to improve its work, and thus achieve its aim of helping people make well-informed decisions about healthcare by providing the best possible evidence on the effects of healthcare interventions.

Awards & Recognition
02/04/2017

Brian MacMahon Early Career Epidemiologist Award

2017: Awarded to Dr. Laura Rosella by the Society for Epidemiologic Research (SER). This annual award acknowledges early career epidemiologists who have made significant contributions to epidemiology through research, teaching, mentoring or service.

Awards & Recognition
09/02/2016

CIHR Canada Research Chair

2016: Awarded to Dr. Laura Rosella for population health analytics.

Awards & Recognition
05/04/2011

Robin Badgley Award for Teaching Excellence

2011: Awarded to Dr. Laura Rosella by the Dalla Lana School of Public Health.

See All

Journal Articles

Journal Article
22/02/2024

Measuring waning protection from seasonal influenza vaccination during nine influenza seasons, Ontario, Canada, 2010/11 to 2018/19

Chung H, Campitelli MA, Buchan SA, Campigotto A, Crowcroft NS, Gubbay JB, Jung JKH, Karnauchow T, Katz K, McGeer AJ, McNally JD, Richardson DC, Richardson SE, Rosella LC, Russell ML, Schwartz KL, Simor A, Smieja M, Sundaram ME, Warshawsky BF, Zahariadis G, Kwong JC; Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators. Euro Surveill. 2024; 29(8):2300239. Epub 2024 Feb 22.

See All
Contact Details

Get in touch with
Laura Rosella

Twitter
@LauraCRosella

"*" indicates required fields

Consent*

The ICES website uses cookies. If that’s okay with you, keep on browsing, or learn more about our Privacy Policy.